Quel est le prix pour Bioqual, Inc. (BIOQ)

Le prix pour Bioqual, Inc. (BIOQ) est $32.50

Quelle est la capitalisation boursière pour Bioqual, Inc. (BIOQ)

La capitalisation boursière pour Bioqual, Inc. (BIOQ) est $29.07M

Bioqual, Inc. (BIOQ) Prix et Capitalisation Boursière

Bioqual, Inc. delivers a range of preclinical research solutions, encompassing both in-vivo and in-vitro methodologies, to its diverse clientele of commercial enterprises and government agencies across the United States. Their expertise spans numerous critical health domains, including investigations into COVID-19, AIDS, influenza, RSV infection, and various flaviviruses such as Zika and Dengue. Furthermore, their work extends to malaria, hepatitis, and oncology. The firm's comprehensive laboratory capabilities further include processing biological samples, producing virus stocks, precisely quantifying infectious viral loads, and conducting assays like virus neutralization and hemagglutination inhibition. They also utilize advanced techniques such as quantitative PCR, ELISA for antigen and antibody detection, flow cytometry, lymphocyte proliferation studies, and various other cell-based analytical methods. Moreover, Bioqual furnishes specialized support for studies employing animal research models. Established in 1981, Bioqual, Inc. maintains its primary operational base in Rockville, Maryland.

Prix pour BIOQ	L’actif B	La capitalisation boursière de B	Résultats
$5,926,240 $29.07M	NVDA	$5.301T	+18,234,483.80%
$5,180,550 $29.07M	AAPL	$4.634T	+15,940,054.75%
$4,631,750 $29.07M	GOOG	$4.143T	+14,251,439.68%
$4,012,830 $29.07M	MSFT	$3.589T	+12,347,070.04%
$3,193,998 $29.07M	AMZN	$2.857T	+9,827,586.61%

Prix pour BIOQ

L’actif B

La capitalisation boursière de B

Résultats

$5,926,240 $29.07M